Park Seung Shin, Kim Jung Hee, Kim Yong Hwy, Lee Jung Hyun, Dho Yun-Sik, Shin Chan Soo
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; Pituitary Center, Seoul National University College of Medicine, Seoul, Korea.
World Neurosurg. 2018 Nov;119:e1035-e1040. doi: 10.1016/j.wneu.2018.08.068. Epub 2018 Aug 23.
Hyperprolactinemia in patients with nonfunctioning pituitary adenomas (NFPAs) has been explained by the stalk compression of large pituitary adenomas. However, not all large NFPAs are associated with high serum prolactin levels. We aimed to elucidate and compare clinical, hormonal, and radiographic characteristics of NFPAs with and without hyperprolactinemia.
We included 201 patients with clinically NFPAs who underwent transsphenoidal surgery performed by a single surgeon during 2010-2017 at a single center in Korea. We measured the three-dimensional diameters (anteroposterior [AP], width, height) and volumes of NFPA on magnetic resonance imaging. We conducted morning basal hormone measurements and dynamic tests preoperatively and 3 months postoperatively.
All NFPAs were macroadenomas, and mean tumor volume was 10.4 ± 7.7 cm. Of 201 patients, 59 (29.4%) had preoperative hyperprolactinemia. Hormone recovery rate was higher in patients with hyperprolactinemia compared with patients without hyperprolactinemia after age, sex, body mass index, tumor volume, and gross total resection adjustments (odds ratio [95% confidence interval]: 2.55 [1.10-5.92]). Tumor width/AP diameter ratio positively correlated with serum prolactin levels (r = 0.186, P = 0.008). Tumor volume was not significantly different between the 2 groups.
Preoperative prolactin level is a useful marker to predict hormone recovery after surgery. Patients with NFPA and hyperprolactinemia tended to have a higher width/AP diameter ratio. Hyperprolactinemia of NFPA is more likely affected by tumor growth pattern, such as width/AP diameter ratio, than tumor volume.
无功能垂体腺瘤(NFPA)患者的高催乳素血症已被解释为大型垂体腺瘤的柄受压所致。然而,并非所有大型NFPA都与血清催乳素水平升高有关。我们旨在阐明并比较有和无高催乳素血症的NFPA的临床、激素和影像学特征。
我们纳入了201例临床上诊断为NFPA的患者,这些患者于2010年至2017年在韩国的一个中心由同一位外科医生进行了经蝶窦手术。我们在磁共振成像上测量了NFPA的三维直径(前后径[AP]、宽度、高度)和体积。我们在术前和术后3个月进行了早晨基础激素测量和动态试验。
所有NFPA均为大腺瘤,平均肿瘤体积为10.4±7.7 cm³。在201例患者中,59例(29.4%)术前有高催乳素血症。在对年龄、性别、体重指数、肿瘤体积和全切除情况进行调整后,有高催乳素血症的患者激素恢复率高于无高催乳素血症的患者(优势比[95%置信区间]:2.55[1.10 - 5.92])。肿瘤宽度/AP直径比与血清催乳素水平呈正相关(r = 0.186,P = 0.008)。两组之间的肿瘤体积无显著差异。
术前催乳素水平是预测术后激素恢复的有用指标。患有NFPA和高催乳素血症的患者往往具有更高的宽度/AP直径比。NFPA的高催乳素血症更可能受肿瘤生长模式(如宽度/AP直径比)的影响,而非肿瘤体积。